The Sky ecosystem plans a Nov. 19 upgrade to connect Osero’s liquidity layer on Ethereum and Base, enabling cross-chain USDC transfers. The upgrade activates Circle’s Cross-Chain Transfer Protocol on both networks, sets transfer limits, and adds a Gauntlet-managed USDC Prime Vault on Base. This change integrates Osero and Prime Agents, which manage a significant portion of Sky’s assets, enhancing asset deployment and risk management. The proposal schedules these changes for the Osero Spell on Nov. 19, marking a key step in Sky’s cross-chain functionality.
The Sky ecosystem upgrade proposal offers context for cryptocurrency market activity. For readers following crypto, here is Pluang's market snapshot as of Nov 07, 2026 09:21 WIB: Of 50 major cryptocurrencies, 37 rose and 12 fell. Bitcoin Cash (BCH) traded at Rp4.787.035 with a 1-day change of -3.58% and 97% sell order activity. Decentraland (MANA) was Rp1.316, up 3.38%, with 85% sell orders. Axie Infinity (AXS) stood at Rp15.445, up 3.31%, with 100% buy orders.
Bitcoin fell to $75,568 and Ether dropped to $2,237, triggering forced liquidations of leveraged positions totaling about $1.033 billion over 24 hours. Most liquidations were long positions, indicating many traders bet on price rises but were caught ...
Allstate reported a strong second quarter, signaling that its business turnaround is complete. The company’s premium growth remains cautious due to conservative underwriting, but both its Auto and Homeowners insurance lines are highly profitable, mai...
Blockstream Research's recent paper identifies Falcon-1024 as the leading lattice-based signature scheme for quantum-proofing Bitcoin due to its compact size and efficient verification. However, significant hurdles remain, including high memory deman...
Myriad Genetics increased its 2026 revenue forecast midpoint to $785 million, citing higher revenue per test that offsets expected softness in its Prenatal Health segment. The company attributes reimbursement challenges mainly to more zero-pay outcom...
Arcutis Biotherapeutics awarded 58,500 restricted stock units and options for 17,000 shares to six new employees as an inducement to join the company. The grants, approved under Nasdaq Listing Rule 5635(c)(4), vest over four years with specific sched...
